These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9707465)

  • 1. Onset of bronchodilation and finger tremor induced by salmeterol and salbutamol in asthmatic patients.
    Lötvall J; Lunde H; Svedmyr N
    Can Respir J; 1998; 5(3):191-4. PubMed ID: 9707465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled dry-powder formoterol and salmeterol in asthmatic patients: onset of action, duration of effect and potency.
    Palmqvist M; Persson G; Lazer L; Rosenborg J; Larsson P; Lötvall J
    Eur Respir J; 1997 Nov; 10(11):2484-9. PubMed ID: 9426083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the bronchodilating effect of salmeterol and zafirlukast in combination with that of their use as single treatments in asthma and chronic obstructive pulmonary disease.
    Cazzola M; Centanni S; Boveri B; Di Marco F; Santus P; Matera MG; Allegra L
    Respiration; 2001; 68(5):452-9. PubMed ID: 11694805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral bambuterol compared to inhaled salmeterol in patients with partially reversible chronic obstructive pulmonary disease.
    Cazzola M; Calderaro F; Califano C; Di Pema F; Vinciguerra A; Donner CF; Matera MG
    Eur J Clin Pharmacol; 1999 Jan; 54(11):829-33. PubMed ID: 10027655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute effects of higher than customary doses of salmeterol and salbutamol in patients with acute exacerbation of COPD.
    Cazzola M; Califano C; Di Perna F; D'Amato M; Terzano C; Matera MG; D'Amato G; Marsico SA
    Respir Med; 2002 Oct; 96(10):790-5. PubMed ID: 12412978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 1-week dose-ranging study of inhaled salmeterol in patients with asthma.
    Bronsky EA; Kemp JP; Orgel HA; Bierman CW; Tinkelman DG; van As A; Liddle RF
    Chest; 1994 Apr; 105(4):1032-7. PubMed ID: 7909285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of salmeterol is independent of previously inhaled salbutamol: a clinical controlled study.
    Wilcke JT; Iversen ET; Kok-Jensen A
    Lung; 1998; 176(2):133-9. PubMed ID: 9500298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of salmeterol xinafoate in the treatment of COPD.
    Mahler DA; Donohue JF; Barbee RA; Goldman MD; Gross NJ; Wisniewski ME; Yancey SW; Zakes BA; Rickard KA; Anderson WH
    Chest; 1999 Apr; 115(4):957-65. PubMed ID: 10208192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twelve months, treatment with inhaled salmeterol in asthmatic patients. Effects on beta 2-receptor function and inflammatory cells.
    Lötvall J; Lunde H; Ullman A; Törnqvist H; Svedmyr N
    Allergy; 1992 Oct; 47(5):477-83. PubMed ID: 1362481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bronchodilator response to salbutamol after chronic dosing with salmeterol or placebo.
    Langley SJ; Masterson CM; Batty EP; Woodcock A
    Eur Respir J; 1998 May; 11(5):1081-5. PubMed ID: 9648959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma.
    D'Alonzo GE; Nathan RA; Henochowicz S; Morris RJ; Ratner P; Rennard SI
    JAMA; 1994 May; 271(18):1412-6. PubMed ID: 7909853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salmeterol xinafoate in asthmatic patients under consideration for maintenance oral corticosteroid therapy. UK Study Group.
    Boyd G
    Eur Respir J; 1995 Sep; 8(9):1494-8. PubMed ID: 8575574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early reversibility to salbutamol does not always predict bronchodilation after salmeterol in stable chronic obstructive pulmonary disease.
    Cazzola M; Vinciguerra A; Di Perna F; Matera MG
    Respir Med; 1998 Aug; 92(8):1012-6. PubMed ID: 9893768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salmeterol and formoterol in partially reversible severe chronic obstructive pulmonary disease: a dose-response study.
    Cazzola M; Matera MG; Santangelo G; Vinciguerra A; Rossi F; D'Amato G
    Respir Med; 1995 May; 89(5):357-62. PubMed ID: 7638371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bronchodilator and bronchoprotective effects of salmeterol in young patients with asthma.
    Simons FE; Soni NR; Watson WT; Becker AB
    J Allergy Clin Immunol; 1992 Nov; 90(5):840-6. PubMed ID: 1358932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients.
    Ullman A; Svedmyr N
    Thorax; 1988 Sep; 43(9):674-8. PubMed ID: 2904183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the bronchodilating effects of salmeterol, salbutamol and ipratropium bromide in patients with chronic obstructive pulmonary disease.
    Matera MG; Cazzola M; Vinciguerra A; Di Perna F; Calderaro F; Caputi M; Rossi F
    Pulm Pharmacol; 1995 Dec; 8(6):267-71. PubMed ID: 8819181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma.
    Cheung D; Timmers MC; Zwinderman AH; Bel EH; Dijkman JH; Sterk PJ
    N Engl J Med; 1992 Oct; 327(17):1198-203. PubMed ID: 1357550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial.
    Baumgartner RA; Hanania NA; Calhoun WJ; Sahn SA; Sciarappa K; Hanrahan JP
    Clin Ther; 2007 Feb; 29(2):261-78. PubMed ID: 17472819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled fluticasone and salmeterol suppress eosinophilic airway inflammation in chronic obstructive pulmonary disease: relations with lung function and bronchodilator reversibility.
    Perng DW; Wu CC; Su KC; Lee YC; Perng RP; Tao CW
    Lung; 2006; 184(4):217-22. PubMed ID: 17006748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.